Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

Stopped early · Phase 1

Conditions studied: Generalized Anxiety Disorder

In brief

The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.

Key facts

Study ID

NCT00800280

Run by

Pfizer

People needed

12

Starts

2009-01-01

Expected to finish

2009-02-01

Last updated by the study team

2010-02-17

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy
• male or female adults

You may not qualify if…

• Current or history of clinically significant medical illness
• Smokers
• Illicit drug use

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.